Abstract
Purpose
The purpose of the study was to evaluate the validity and reliability of a short-form Revised Lifestyle Evaluation Scale for Metabolic Syndrome (RLES-MS)–Korean.
Methods
A cross-sectional survey was administered to 211 people with diabetes who were taking medication for metabolic syndrome and attending an outpatient clinic at a university-affiliated hospital in Suwon, Korea. Structured questionnaires were used for the psychometric evaluation. The RLES-MS validity was examined using exploratory factor analysis, and reliability was assessed using Cronbach’s alpha and McDonald’s omega.
Results
The interitem correlation analyses identified 2 low-correlation items, resulting in a 15-item scale. Factor analysis identified 4 dimensions of the RLES-MS: healthy eating and being active, monitoring and managing target goals, healthy coping, and awareness and taking medication. The 4-factor model explained 58.65% of the total variance. Item 8 (taking medication) scored the highest, and Item 2 (healthy eating) scored the lowest, followed by Item 13 (monitoring and managing the target values). Overall, Cronbach’s alpha and McDonald’s omega were .864 and .866, respectively. The RLES-MS showed significant associations with quality of life (r = .426, P < .001), self-efficacy (r = .530, P < .001), depressive symptoms (r = −.430, P < .001), and A1C (r = −.163, P = .018).
Conclusions
The RLES-MS showed good validity and moderate reliability, supporting its clinical use for evaluating lifestyle behaviors in Korean people with diabetes and metabolic syndrome.
Get full access to this article
View all access options for this article.
